ArticleImmunology2021

Post-transplant cyclophosphamide limits reactive donor T cells and delays the development of graft-versus-host disease in a humanized mouse model.

Sam R Adhikary et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.